Personalized Medicine – News and Features

A 3D tumor model around the size of a pencil eraser could help treat glioblastoma with personalized therapies by accurately replicating the tumor microenvironment.

In this interview, Rolland Carlson, PhD, CEO of Immunexpress, discusses sepsis and the company’s FDA cleared SeptiCyte® RAPID test, as well as a take on the company’s differentiated value and outlook.

The treatment of chronic disease needs a revolution. Discover in this article how precision medicine can help to make treatment more tailored to individuals and the underlying causes of their disease.

In this article, Dr. Jane Lomax provides an overview of ontologies and describes how they can help to overcome big data challenges.

The discovery of molecular signatures of the incurable eye disease, age-related macular degeneration, could improve diagnosis and treatment.

A new paper that reviews the evidence around the serotonin “chemical imbalance” theory of depression has caused an online storm, with figures from across psychiatry commenting on the study’s merits and limitations. In this article, we take a look at what the paper has changed about our understanding of depression.

Researchers have developed a new blood test that provides unprecedented insight into a patient’s cancer make-up, potentially allowing doctors to better select treatment options that will improve outcomes.

Patient-derived organoids could help direct pancreatic cancer treatment strategy, as they can predict how the tumor will respond to chemotherapy before surgery.

Researchers have developed a network-based machine learning method to improve the accuracy of predicting patient response to immune checkpoint inhibitors (ICIs).

A preclinical study investigating the use of a trio of drugs for treating pancreatic cancer and preventing metastasis has shown promise.